Herbalife Ltd. (NYSE: HLF) experienced a significant surge in its stock price during post-market trading on Wednesday, with shares soaring 12.45%. The dramatic after-hours movement followed the release of the company's latest financial results and a major strategic announcement.

The stock's sharp rise was driven by two primary factors. First, the nutrition company announced that global football icon Cristiano Ronaldo has invested $7.5 million in Herbalife's Pro2col™ personalized nutrition technology, acquiring a 10% equity stake in the software subsidiary. This high-profile endorsement and investment signal strong confidence in Herbalife's technological innovation and growth prospects in personalized nutrition.

Second, Herbalife reported fourth-quarter 2025 results that substantially exceeded analyst expectations. The company posted adjusted earnings per share of $0.45, beating the consensus estimate of $0.43 by 5.63%. Quarterly sales reached $1.283 billion, surpassing the $1.244 billion estimate by 3.12% and representing a 6.3% year-over-year increase. Additionally, adjusted EBITDA of $156.1 million exceeded the $150.2 million estimate. The company also provided encouraging guidance for 2026, forecasting first-quarter net sales growth of 3-7% and full-year growth of 1-6%.